Want to track CTMX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
CytomX Therapeutics (CTMX) Q3 Earnings and Revenues Top Estimates
CytomX Therapeutics (CTMX) came out with quarterly earnings of $0.07 per share, beating the Zacks Consensus Estimate of a loss of $0.16 per share. This compares to earnings of $0.04 per share a year ago.
Zacks | 1 year ago
Buy Alert: 3 Penny Stocks That Will Explode in 2024
When the term penny stocks to buy is thrown around, ideas of high-risk-high-reward, overnight wealth generation and potential scams may come to mind. However, investing in carefully-selected penny stocks can yield a much less volatile experience.
Investorplace | 2 years ago
